WCK-4234 sodium

CAS No. 1804915-68-1

WCK-4234 sodium ( WCK-4234; WCK 4234; WCK4234 )

Catalog No. M27755 CAS No. 1804915-68-1

WCK-4234 sodium is an inhibitor of β-lactamase can be used in studies targeting MDR infections. WCK-4234 sodium inhibits class A, C, and D β-lactamases and OXA carbapenemases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 192 Get Quote
10MG 282 Get Quote
25MG 480 Get Quote
50MG 691 Get Quote
100MG 972 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    WCK-4234 sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    WCK-4234 sodium is an inhibitor of β-lactamase can be used in studies targeting MDR infections. WCK-4234 sodium inhibits class A, C, and D β-lactamases and OXA carbapenemases.
  • Description
    WCK-4234 sodium is an inhibitor of β-lactamase can be used in studies targeting MDR infections. WCK-4234 sodium inhibits class A, C, and D β-lactamases and OXA carbapenemases.
  • Synonyms
    WCK-4234; WCK 4234; WCK4234
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    RORγt
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1804915-68-1
  • Formula Weight
    269.2
  • Molecular Formula
    C7H8N3NaO5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [Na+].[H]C12CN(C(CC1)C#N)C(=O)N2OS([O-])(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jill Skepner, et al. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. J Immunol. 2014 Mar 15;192(6):2564-75.
molnova catalog
related products
  • Sulfaproxiline

    Sulfaproxiline is a synthetic antibacterial drug of sulfonamide.

  • Capreomycin sulfate

    A peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis.

  • Demeclocycline hydro...

    A tetracycline antibiotic that acts by binding to the 30S ribosomal subunit to inhibit binding of aminoacyl tRNA which impairs protein synthesis by bacteria.